MicroTech Medical (Hangzhou) Balance Sheet Health
Financial Health criteria checks 5/6
MicroTech Medical (Hangzhou) has a total shareholder equity of CN¥2.0B and total debt of CN¥20.0M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥2.2B and CN¥155.4M respectively.
Key information
1.0%
Debt to equity ratio
CN¥20.01m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.81b |
| Equity | CN¥2.01b |
| Total liabilities | CN¥155.39m |
| Total assets | CN¥2.17b |
Recent financial health updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Recent updates
MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Sep 22News Flash: One MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Analyst Has Been Trimming Their Revenue Forecasts
Jan 20MicroTech Medical (Hangzhou) (HKG:2235) Is In A Good Position To Deliver On Growth Plans
Jan 18Financial Position Analysis
Short Term Liabilities: 2235's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥150.8M).
Long Term Liabilities: 2235's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥4.6M).
Debt to Equity History and Analysis
Debt Level: 2235 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2235's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2235 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 2235 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 36.9% each year